Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Mayo Clinic |
---|---|
Information provided by: | Mayo Clinic |
ClinicalTrials.gov Identifier: | NCT00588250 |
Hypothesis: a special solution for improving human embryo implantation, when added to the solution during embryo transfer, will improve implantation rates in embryo transfers using previously frozen embryos.
Condition | Intervention |
---|---|
Embryo Implantation Infertility |
Other: EmbryoGlue |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Single Group Assignment |
Official Title: | Prospective Randomized Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates |
Enrollment: | 150 |
Study Start Date: | May 2003 |
Estimated Study Completion Date: | June 2005 |
Primary Completion Date: | June 2005 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Experimental |
Other: EmbryoGlue
G2 culture media from Vitrolife which contains hyaluronic acid
|
B: No Intervention |
EmbryoGlue (TM) is added to embryo transfer solutions immediately prior to the transfer of frozen-thawed human embryos before placement of embryos into the patient uterus.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Mayo Clinic ( Dean E. Morbeck, PhD ) |
Study ID Numbers: | 876-04 |
Study First Received: | December 22, 2007 |
Last Updated: | December 22, 2007 |
ClinicalTrials.gov Identifier: | NCT00588250 |
Health Authority: | United States: Food and Drug Administration |
Genital Diseases, Female Infertility Hyaluronic Acid Genital Diseases, Male |